A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective.
Steve RyderKathleen FoxPratik RaneNigel ArmstrongChing-Yun WeiSohan DeshpandeLisa StirkYi QianJos KleijnenPublished in: PharmacoEconomics (2020)
There was considerable unexplained variation in contemporary costs for all major cardiovascular events. One emerging theme was that average costs in the USA were considerably higher than anywhere else.